Clinical Trial

Strategy for Unstable Coronary Plaque in Patients Presenting to Emergency Department for Chest Pain Suspected of Coronary Artery Disease

Study acronym: SPECTRE
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Primary prevention of coronary disease and especially its major complication, inaugural myocardial infarction, is based on any prodromal symptoms identification and on risk profile establishment. About 50% of myocardial infarctions are caused by an unstable non-stenosing plaque, asymptomatic before the event since without significant reduction in coronary flow, particularly during a stress test or during stress imaging. Study purpose is to set up, in medical emergency department, check-up unit and cardiology department, a primary prevention strategy articulated around a routine examination: calcium scoring. The latter makes it possible to categorize patients according to their risk of generating atheromatous plaques and to classify them into several risk levels (groups) according to their score: low (\<40th percentile), intermediate (between the 40th percentile and the 65th percentile: group III) or high risk (\>65th percentile, group IV). 18F-Na PET scan can mark unstable coronary plaques. For the intermediate risk population who would demonstrate within 6 to 18 months after first calcium score either an increase of percentile of more than 20% or an increase above 20 points of the calcium score and for high risk population, 18F-Na PET scan will be recommended and repeated 6 months later. Secondary prevention treatment will then be administered in the event of an abnormal examination.
Protocol Amendment History 4 changes
notable Primary completion moved earlier: 2026-11 -> 2025-07-24 2026-06-17
minor Completion moved earlier: 2028-03 -> 2027-11-24 2026-06-17
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-04-14
notable Enrollment reduced: 250 -> 22 participants 2026-04-14
Trial Details
NCT Number NCT06013722
Lead Sponsor Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Collaborators: Monaco Scientific center
Conditions Atherosclerosis
Enrollment 22 participants
Start Date 2024-03-18
Primary Completion 2025-07-24 (estimated)
Study Completion 2027-11-24 (estimated)
Updated on ClinicalTrials.gov 2026-07-07